Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001876657-22-000003
Filing Date
2022-11-18
Accepted
2022-11-18 14:19:12
Documents
1
Effectiveness Date
2022-11-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7452
  Complete submission text file 0001876657-22-000003.txt   8520
Mailing Address 1214 RESEARCH BOULEVARD, SUITE 2010 HUMMELSTOWN PA 17036
Business Address 1214 RESEARCH BOULEVARD, SUITE 2010 HUMMELSTOWN PA 17036 610-321-3111
SIRPant Immunotherapeutics, Inc. (Filer) CIK: 0001876657 (see all company filings)

EIN.: 850962670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-408981 | Film No.: 221401484